CD2AP and glioblastoma: Moreover, we found that the expressions of several known NF-κB target genes conferring antiapoptotic properties, such as CFLAR, TRAF2, IEX-1L, and MNSOD [21] were elevated in GBM cells with CD2AP overexpression (Supplementary Fig. S4D, E).